AMSTERDAM – Belgian pharmaceutical compounding giant Fagron NV announced on Friday two strategic acquisitions to expand its presence in Asia-Pacific and Brazil, coupled with a crucial regulatory license in the United States, marking a significant step in its global growth strategy.
The company said it has acquired Amber Compounding Pharmacy, a leader in Singapore and Malaysia, and has agreed to buy Brazil’s Vepakum, a specialized packaging manufacturer. The deals, with a combined purchase price of approximately 55 million euros ($59.5 million), are projected to add about 26 million euros in annual revenue.
In a parallel development critical for its North American operations, Fagron’s Anazao Health facility in Tampa, Florida, received a license from the California State Board of Pharmacy. This allows the shipment of patient-specific compounded medications to California, one of the largest and most regulated U.S. healthcare markets.
“The acquisitions and the licensing milestone are pivotal in executing our strategy to build a leading global platform in compounding,” a Fagron spokesperson told Reuters. “They enhance our geographic diversity, add new capabilities, and strengthen our operational network.”
The acquisition of Amber, Fagron’s second move in the APAC region after buying Australia’s Bella Corp, gives it five strategic locations in the fast-growing Singapore and Malaysian markets. The purchase of Vepakum, conditional on antitrust clearance in Brazil, moves Fagron into the packaging vertical, aiming to create scale benefits in distribution and services.
The newly licensed Florida facility will now serve California, enabling Fagron to consolidate operations, eliminate overlapping costs from a former site, and establish a coast-to-coast platform for its Health and Wellness business in the United States.
Fagron stated the acquired businesses boast an EBITDA margin exceeding the group’s current average. The transactions imply an average enterprise value to EBITDA multiple of around 8 times.
In a separate board update, the company announced Klaus Röhrig, representing major shareholder Active Ownership S.à r.l. (AOC), voluntarily stepped down on Nov. 30. He has been replaced by Philipp Klecka as a non-executive director representing AOC, effective Dec. 1.
($1 = 0.9247 euros)